Josine E. Verhoeven , Laura K.M. Han , Bianca A. Lever-van Milligen , Mandy X. Hu , Dóra Révész , Adriaan W. Hoogendoorn , Neeltje M. Batelaan , Digna J.F. van Schaik , Anton J.L.M. van Balkom , Patricia van Oppen , Brenda W.J.H. Penninx
{"title":"抗抑郁药或跑步疗法:比较抑郁症和焦虑症患者的精神和身体健康效果","authors":"Josine E. Verhoeven , Laura K.M. Han , Bianca A. Lever-van Milligen , Mandy X. Hu , Dóra Révész , Adriaan W. Hoogendoorn , Neeltje M. Batelaan , Digna J.F. van Schaik , Anton J.L.M. van Balkom , Patricia van Oppen , Brenda W.J.H. Penninx","doi":"10.1016/j.jad.2023.02.064","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Antidepressant medication and running therapy are both effective treatments for patients with depressive and anxiety disorders. However, they may work through different pathophysiological mechanisms and could differ in their impact on physical health. This study examined effects of antidepressants versus running therapy on both mental and physical health.</p></div><div><h3>Methods</h3><p>According to a partially randomized patient preference design, 141 patients with depression and/or anxiety disorder were randomized or offered preferred 16-week treatment: antidepressant medication (escitalopram or sertraline) or group-based running therapy ≥2 per week. Baseline (T0) and post-treatment assessment at week 16 (T16) included mental (diagnosis status and symptom severity) and physical health indicators (metabolic and immune indicators, heart rate (variability), weight, lung function, hand grip strength, fitness).</p></div><div><h3>Results</h3><p>Of the 141 participants (mean age 38.2 years; 58.2 % female), 45 participants received antidepressant medication and 96 underwent running therapy. Intention-to-treat analyses showed that remission rates at T16 were comparable (antidepressants: 44.8 %; running: 43.3 %; p = .881). However, the groups differed significantly on various changes in physical health: weight (d = 0.57; p = .001), waist circumference (d = 0.44; p = .011), systolic (d = 0.45; p = .011) and diastolic (d = 0.53; p = .002) blood pressure, heart rate (d = 0.36; p = .033) and heart rate variability (d = 0.48; p = .006).</p></div><div><h3>Limitations</h3><p>A minority of the participants was willing to be randomized; the running therapy was larger due to greater preference for this intervention.</p></div><div><h3>Conclusions</h3><p>While the interventions had comparable effects on mental health, running therapy outperformed antidepressants on physical health, due to both larger improvements in the running therapy group as well as larger deterioration in the antidepressant group.</p></div><div><h3>Trial registration</h3><p>Trialregister.nl Number of identification: NTR3460.</p></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"329 ","pages":"Pages 19-29"},"PeriodicalIF":4.9000,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Antidepressants or running therapy: Comparing effects on mental and physical health in patients with depression and anxiety disorders\",\"authors\":\"Josine E. Verhoeven , Laura K.M. Han , Bianca A. Lever-van Milligen , Mandy X. Hu , Dóra Révész , Adriaan W. Hoogendoorn , Neeltje M. Batelaan , Digna J.F. van Schaik , Anton J.L.M. van Balkom , Patricia van Oppen , Brenda W.J.H. Penninx\",\"doi\":\"10.1016/j.jad.2023.02.064\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Antidepressant medication and running therapy are both effective treatments for patients with depressive and anxiety disorders. However, they may work through different pathophysiological mechanisms and could differ in their impact on physical health. This study examined effects of antidepressants versus running therapy on both mental and physical health.</p></div><div><h3>Methods</h3><p>According to a partially randomized patient preference design, 141 patients with depression and/or anxiety disorder were randomized or offered preferred 16-week treatment: antidepressant medication (escitalopram or sertraline) or group-based running therapy ≥2 per week. Baseline (T0) and post-treatment assessment at week 16 (T16) included mental (diagnosis status and symptom severity) and physical health indicators (metabolic and immune indicators, heart rate (variability), weight, lung function, hand grip strength, fitness).</p></div><div><h3>Results</h3><p>Of the 141 participants (mean age 38.2 years; 58.2 % female), 45 participants received antidepressant medication and 96 underwent running therapy. Intention-to-treat analyses showed that remission rates at T16 were comparable (antidepressants: 44.8 %; running: 43.3 %; p = .881). However, the groups differed significantly on various changes in physical health: weight (d = 0.57; p = .001), waist circumference (d = 0.44; p = .011), systolic (d = 0.45; p = .011) and diastolic (d = 0.53; p = .002) blood pressure, heart rate (d = 0.36; p = .033) and heart rate variability (d = 0.48; p = .006).</p></div><div><h3>Limitations</h3><p>A minority of the participants was willing to be randomized; the running therapy was larger due to greater preference for this intervention.</p></div><div><h3>Conclusions</h3><p>While the interventions had comparable effects on mental health, running therapy outperformed antidepressants on physical health, due to both larger improvements in the running therapy group as well as larger deterioration in the antidepressant group.</p></div><div><h3>Trial registration</h3><p>Trialregister.nl Number of identification: NTR3460.</p></div>\",\"PeriodicalId\":14963,\"journal\":{\"name\":\"Journal of affective disorders\",\"volume\":\"329 \",\"pages\":\"Pages 19-29\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2023-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of affective disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0165032723002239\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of affective disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165032723002239","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Antidepressants or running therapy: Comparing effects on mental and physical health in patients with depression and anxiety disorders
Background
Antidepressant medication and running therapy are both effective treatments for patients with depressive and anxiety disorders. However, they may work through different pathophysiological mechanisms and could differ in their impact on physical health. This study examined effects of antidepressants versus running therapy on both mental and physical health.
Methods
According to a partially randomized patient preference design, 141 patients with depression and/or anxiety disorder were randomized or offered preferred 16-week treatment: antidepressant medication (escitalopram or sertraline) or group-based running therapy ≥2 per week. Baseline (T0) and post-treatment assessment at week 16 (T16) included mental (diagnosis status and symptom severity) and physical health indicators (metabolic and immune indicators, heart rate (variability), weight, lung function, hand grip strength, fitness).
Results
Of the 141 participants (mean age 38.2 years; 58.2 % female), 45 participants received antidepressant medication and 96 underwent running therapy. Intention-to-treat analyses showed that remission rates at T16 were comparable (antidepressants: 44.8 %; running: 43.3 %; p = .881). However, the groups differed significantly on various changes in physical health: weight (d = 0.57; p = .001), waist circumference (d = 0.44; p = .011), systolic (d = 0.45; p = .011) and diastolic (d = 0.53; p = .002) blood pressure, heart rate (d = 0.36; p = .033) and heart rate variability (d = 0.48; p = .006).
Limitations
A minority of the participants was willing to be randomized; the running therapy was larger due to greater preference for this intervention.
Conclusions
While the interventions had comparable effects on mental health, running therapy outperformed antidepressants on physical health, due to both larger improvements in the running therapy group as well as larger deterioration in the antidepressant group.
Trial registration
Trialregister.nl Number of identification: NTR3460.
期刊介绍：
The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, mood spectrum, emotions and personality, anxiety and stress. It is interdisciplinary and aims to bring together different approaches for a diverse readership. Top quality papers will be accepted dealing with any aspect of affective disorders, including neuroimaging, cognitive neurosciences, genetics, molecular biology, experimental and clinical neurosciences, pharmacology, neuroimmunoendocrinology, intervention and treatment trials.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
